[HAART influences the lipids].
Behrens
Georg
G
Klinik für Immunologie und Rheumatologie, Medizinische Hochschule Hannover. behrens.georg@mh-hannover.de
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D050197:Atherosclerosis / Q000139:chemically induced / Q000517:prevention & control; D015658:HIV Infections / Q000188:drug therapy*; D015438:Health Behavior; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000139:chemically induced* / Q000517:prevention & control; D015228:Hypertriglyceridemia / Q000139:chemically induced* / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008019:Life Style; D024821:Metabolic Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000517:prevention & control; D018570:Risk Assessment
D019380:Anti-HIV Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007004:Hypoglycemic Agents